The Best AI Stock to Own in the World Today is Trading for Just $25

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

RVNC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $7,128,621.54

Revance Therapeutics Insider Trading History Chart

Revance Therapeutics Share Price & Price History

^$3.40

▲ +0.11 (3.34%)

As of 04/26/2024 05:28 PM ET

Days: 30 | 90 | 365

The Next Step of Their Control Is Here …

From Weiss Ratings | Ad

Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.

4 simple steps to protect your privacy and money before it’s too late.

Revance Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/16/2024	Erica Jordan	Insider	Sell	2,392	$3.80	$9,089.60	114,864
3/18/2024	Dustin S Sjuts	President	Sell	9,211	$5.04	$46,423.44	167,550
3/18/2024	Dwight Moxie	Insider	Sell	8,125	$5.04	$40,950.00	137,815
3/18/2024	Tobin Schilke	CFO	Sell	9,361	$5.04	$47,179.44	192,666
9/5/2023	Dwight Moxie	SVP	Sell	23,853	$17.81	$424,821.93	55,066
8/3/2023	Mark J. Foley	CEO	Sell	26,279	$22.57	$593,117.03	840,375
7/3/2023	Mark J. Foley	CEO	Sell	26,279	$24.94	$655,398.26	866,654
7/3/2023	Tobin Schilke	CFO	Sell	1,701	$25.04	$42,593.04	79,896
6/15/2023	Carey Oconnor Kolaja	Director	Sell	2,500	$28.24	$70,600.00	16,561
6/9/2023	Dustin S Sjuts	President	Sell	5,000	$30.82	$154,100.00	147,347
6/9/2023	Mark J. Foley	CEO	Sell	31,279	$30.72	$960,890.88	891,933
6/1/2023	Tobin Schilke	CFO	Sell	2,701	$30.57	$82,569.57	81,328
5/15/2023	Dustin S Sjuts	President	Sell	21,015	$34.55	$726,068.25	152,347
5/15/2023	Dwight Moxie	SVP	Sell	21,401	$34.55	$739,404.55	69,165
5/15/2023	Mark J. Foley	CEO	Sell	70,447	$34.55	$2,433,943.85	923,212
5/1/2023	Tobin Schilke	CFO	Sell	3,201	$31.70	$101,471.70	63,081
4/3/2023	Tobin Schilke	CFO	Sell	3,201	$32.15	$102,912.15	66,282
3/9/2023	Dustin S Sjuts	President	Sell	21,508	$31.59	$679,437.72	123,934
3/9/2023	Dwight Moxie	SVP	Sell	18,496	$31.59	$584,288.64	55,547
3/9/2023	Mark J. Foley	CEO	Sell	70,390	$31.59	$2,223,620.10	823,351
3/9/2023	Tobin Schilke	CFO	Sell	18,517	$31.59	$584,952.03	73,222
3/1/2023	Tobin Schilke	CFO	Sell	3,201	$33.50	$107,233.50	49,390
2/1/2023	Tobin Schilke	CFO	Sell	3,201	$34.60	$110,754.60	54,676
1/20/2023	Tobin Schilke	CFO	Sell	1,000	$31.00	$31,000.00	57,877
1/9/2023	Tobin Schilke	CFO	Sell	3,701	$27.16	$100,519.16	58,877
9/14/2022	Dwight Moxie	SVP	Sell	11,000	$27.07	$297,770.00	31,694
12/13/2021	Angus C. Russell	Director	Buy	6,400	$15.74	$100,736.00
12/3/2021	Aubrey Rankin	Insider	Buy	30,000	$14.43	$432,900.00
11/29/2021	Mark J. Foley	CEO	Buy	40,000	$12.90	$516,000.00
9/27/2021	Dwight Moxie	SVP	Sell	1,675	$30.00	$50,250.00
8/16/2021	Aubrey Rankin	Insider	Sell	9,364	$26.34	$246,647.76
7/28/2021	Aubrey Rankin	Insider	Sell	54,332	$30.06	$1,633,219.92	79,776
7/26/2021	Aubrey Rankin	Insider	Sell	55,382	$29.72	$1,645,953.04	79,776

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

SEC Filings (Institutional Ownership Changes) for Revance Therapeutics (NASDAQ:RVNC)

97.70% of Revance Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Revance Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/23/2024	Rice Hall James & Associates LLC	746,139	$3.67M	0.2%	-1.6%	0.716%
4/5/2024	Los Angeles Capital Management LLC	92,918	$0.46M	0.0%	N/A	0.089%
3/26/2024	HighPoint Advisor Group LLC	11,157	$98K	0.0%	N/A	0.011%
3/5/2024	Wellington Management Group LLP	449,685	$3.95M	0.0%	-58.5%	0.510%
2/26/2024	Centaurus Financial Inc.	17,612	$0.16M	0.0%	-28.2%	0.020%
2/26/2024	Virtu Financial LLC	24,946	$0.22M	0.0%	-31.4%	0.028%
2/22/2024	Sierra Summit Advisors LLC	86,421	$0.76M	0.2%	N/A	0.098%
2/14/2024	Nebula Research & Development LLC	105,295	$0.93M	0.3%	N/A	0.120%
2/14/2024	Rubric Capital Management LP	1,461,474	$12.85M	0.3%	-8.7%	1.664%
2/13/2024	Tower Research Capital LLC TRC	6,823	$60K	0.0%	+626.6%	0.008%
2/13/2024	Capital World Investors	11,939,076	$104.94M	0.0%	-0.2%	13.596%
2/13/2024	DCF Advisers LLC	256,872	$2.26M	1.2%	+869.3%	0.293%
2/13/2024	Rhenman & Partners Asset Management AB	475,872	$4.18M	0.4%	+31.6%	0.542%
2/13/2024	CIBC Asset Management Inc	1,147,294	$10.09M	0.0%	+251.2%	1.307%
2/12/2024	Capstone Investment Advisors LLC	19,449	$0.17M	0.0%	N/A	0.022%
2/9/2024	Aigen Investment Management LP	19,569	$0.17M	0.0%	N/A	0.022%
2/9/2024	Quest Partners LLC	9,532	$84K	0.0%	N/A	0.011%
2/9/2024	Trexquant Investment LP	65,759	$0.58M	0.0%	N/A	0.075%
2/9/2024	Dynamic Technology Lab Private Ltd	27,370	$0.24M	0.0%	N/A	0.031%
2/8/2024	Great Lakes Advisors LLC	233,958	$2.06M	0.0%	+5.3%	0.266%
2/8/2024	Fairhaven Wealth Management LLC	14,859	$0.13M	0.0%	N/A	0.017%
2/8/2024	Essex Investment Management Co. LLC	122,419	$1.08M	0.2%	+46.2%	0.139%
2/7/2024	Principal Financial Group Inc.	269,718	$2.37M	0.0%	-72.0%	0.307%
2/7/2024	BNP Paribas Financial Markets	47,886	$0.42M	0.0%	-66.3%	0.055%
2/7/2024	Teacher Retirement System of Texas	19,357	$0.17M	0.0%	-18.9%	0.022%
2/7/2024	Versor Investments LP	13,500	$0.12M	0.0%	N/A	0.015%
2/6/2024	Charles Schwab Investment Management Inc.	677,364	$5.95M	0.0%	+2.1%	0.771%
2/6/2024	Swiss National Bank	164,650	$1.45M	0.0%	-10.9%	0.188%
2/5/2024	Victory Capital Management Inc.	10,554	$93K	0.0%	N/A	0.012%
2/5/2024	Sargent Investment Group LLC	13,822	$0.12M	0.0%	N/A	0.016%
2/1/2024	Jennison Associates LLC	1,032,352	$9.07M	0.0%	+3.5%	1.176%
2/1/2024	Handelsbanken Fonder AB	20,800	$0.18M	0.0%	+54.1%	0.024%
1/31/2024	Federated Hermes Inc.	82,177	$0.72M	0.0%	+111.9%	0.094%
1/24/2024	China Universal Asset Management Co. Ltd.	10,155	$89K	0.0%	+351.3%	0.012%
1/17/2024	Assenagon Asset Management S.A.	198,846	$1.75M	0.0%	-52.0%	0.226%
1/16/2024	Legato Capital Management LLC	57,652	$0.51M	0.1%	+48.8%	0.066%
1/12/2024	SG Americas Securities LLC	62,598	$0.55M	0.0%	N/A	0.071%
1/9/2024	Daymark Wealth Partners LLC	29,000	$0.26M	0.0%	+20.8%	0.033%
1/8/2024	Harbor Capital Advisors Inc.	55,422	$0.49M	0.1%	+35.2%	0.063%
1/4/2024	DNB Asset Management AS	34,652	$0.31M	0.0%	+44.7%	0.039%
12/18/2023	Vanguard Group Inc.	4,791,459	$54.96M	0.0%	+3.0%	5.457%
12/13/2023	Teachers Retirement System of The State of Kentucky	40,431	$0.46M	0.0%	+47.6%	0.046%
12/1/2023	Wellington Management Group LLP	1,082,420	$12.42M	0.0%	+3.6%	1.233%
11/22/2023	Polar Capital Holdings Plc	4,160,311	$47.72M	0.3%	-0.2%	4.738%
11/22/2023	Public Sector Pension Investment Board	176,000	$2.02M	0.0%	-30.7%	0.200%
11/15/2023	Rubric Capital Management LP	1,600,000	$18.35M	0.7%	N/A	1.822%
11/15/2023	EULAV Asset Management	600,000	$6.88M	0.3%	+275.0%	0.683%
11/14/2023	Lazard Asset Management LLC	77,200	$0.89M	0.0%	-99.4%	0.088%
11/14/2023	Schonfeld Strategic Advisors LLC	201,634	$2.31M	0.0%	+140.0%	0.230%
11/14/2023	Rubric Capital Management LP	1,600,000	$18.35M	0.7%	N/A	1.822%
11/14/2023	Nomura Holdings Inc.	22,500	$0.26M	0.0%	N/A	0.026%
11/14/2023	Bamco Inc. NY	1,020,234	$11.70M	0.0%	-9.1%	1.162%
11/14/2023	Profund Advisors LLC	34,961	$0.40M	0.0%	+87.9%	0.040%
11/13/2023	Federated Hermes Inc.	38,788	$0.45M	0.0%	+502.0%	0.044%
11/13/2023	Invesco Ltd.	2,902,440	$33.29M	0.0%	+66.0%	3.305%
11/13/2023	FMR LLC	1,894,107	$21.73M	0.0%	-3.2%	2.157%
11/13/2023	Rafferty Asset Management LLC	20,491	$0.24M	0.0%	+127.3%	0.023%
11/13/2023	Rhenman & Partners Asset Management AB	361,679	$4.15M	0.4%	+194.0%	0.412%
11/9/2023	Deutsche Bank AG	45,042	$0.52M	0.0%	+13.1%	0.051%
11/9/2023	Essex Investment Management Co. LLC	83,748	$0.96M	0.2%	-23.1%	0.095%
11/9/2023	Innovis Asset Management LLC	38,501	$0.44M	0.2%	+266.1%	0.044%
11/9/2023	Canada Pension Plan Investment Board	7,700	$88K	0.0%	N/A	0.009%
11/8/2023	Campbell & CO Investment Adviser LLC	100,907	$1.16M	0.1%	+537.3%	0.115%
11/8/2023	Charles Schwab Investment Management Inc.	663,538	$7.61M	0.0%	+5.8%	0.754%
11/8/2023	Swiss National Bank	184,750	$2.12M	0.0%	+1.2%	0.210%
11/7/2023	Great Lakes Advisors LLC	222,077	$2.55M	0.0%	+13.7%	0.252%
11/7/2023	Fox Run Management L.L.C.	18,360	$0.21M	0.1%	N/A	0.021%
11/7/2023	Jump Financial LLC	18,122	$0.21M	0.0%	-86.0%	0.021%
11/6/2023	Assenagon Asset Management S.A.	414,055	$4.75M	0.0%	N/A	0.471%
11/6/2023	Los Angeles Capital Management LLC	18,976	$0.22M	0.0%	+122.5%	0.022%
11/2/2023	Rice Hall James & Associates LLC	683,937	$7.85M	0.5%	+23.8%	0.778%
11/2/2023	Principal Financial Group Inc.	963,029	$11.05M	0.0%	+55.2%	1.095%
11/2/2023	RF&L Wealth Management LLC	28,000	$0.32M	0.3%	+40.0%	0.032%
10/31/2023	Jennison Associates LLC	997,616	$11.44M	0.0%	-45.8%	1.134%
10/30/2023	CIBC Asset Management Inc	326,707	$3.75M	0.0%	+40.2%	0.371%
10/27/2023	Allspring Global Investments Holdings LLC	4,424	$51K	0.0%	-99.6%	0.005%
10/27/2023	Assetmark Inc.	3,257	$37K	0.0%	+63.2%	0.004%
10/26/2023	Inspire Investing LLC	26,592	$0.31M	0.0%	+113.7%	0.030%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	18,083	$0.21M	0.0%	+17.0%	0.021%
10/23/2023	Commonwealth Equity Services LLC	99,129	$1.14M	0.0%	+3.6%	0.113%
10/20/2023	Harbor Capital Advisors Inc.	40,999	$0.47M	0.1%	+29.4%	0.047%
10/13/2023	DnB Asset Management AS	23,946	$0.28M	0.0%	+10.0%	0.027%
10/10/2023	Daymark Wealth Partners LLC	24,000	$0.28M	0.0%	+71.4%	0.027%
9/21/2023	Barclays PLC	280,758	$7.11M	0.0%	+1.0%	0.319%
8/18/2023	Legato Capital Management LLC	39,766	$1.01M	0.1%	+18.9%	0.045%
8/14/2023	NinePointTwo Capital LLC	8,444	$0.21M	0.1%	N/A	0.010%
8/14/2023	West Tower Group LLC	1,548	$39K	0.0%	N/A	0.002%
8/14/2023	UniSuper Management Pty Ltd	317,680	$8.04M	0.1%	N/A	0.361%
8/14/2023	Driehaus Capital Management LLC	201,566	$5.10M	0.1%	N/A	0.229%
8/14/2023	Thrivent Financial for Lutherans	3,247,319	$82.19M	0.2%	+60.7%	3.692%
8/14/2023	Granahan Investment Management LLC	288,927	$7.31M	0.2%	+18.7%	0.328%
8/11/2023	Campbell & CO Investment Adviser LLC	15,833	$0.40M	0.1%	N/A	0.018%
8/11/2023	Capital World Investors	9,574,874	$242.34M	0.0%	-5.0%	10.885%
8/11/2023	Sei Investments Co.	271,079	$6.86M	0.0%	-5.3%	0.308%
8/11/2023	Rhenman & Partners Asset Management AB	123,000	$3.11M	0.3%	-46.5%	0.140%
8/11/2023	JPMorgan Chase & Co.	4,693,888	$118.80M	0.0%	-9.1%	5.336%
8/11/2023	ExodusPoint Capital Management LP	27,345	$0.69M	0.0%	N/A	0.031%
8/10/2023	MetLife Investment Management LLC	43,980	$1.11M	0.0%	+3.9%	0.052%
8/10/2023	ProShare Advisors LLC	16,288	$0.41M	0.0%	+6.9%	0.019%
8/10/2023	Profund Advisors LLC	18,606	$0.47M	0.0%	+9.3%	0.022%

Data available starting January 2016

Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DAXXIFY (DaxibotulinumtoxinA-lanm) for injection for the treatment of glabellar lines and cervical dystonia; has completed phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing OnabotulinumtoxinA, a biosimilar to BOTOX that is in preclinical stage. The company also offers Resilient Hyaluronic Acid (RHA) dermal filler for the correction of moderate to severe dynamic facial wrinkles; and RHA Redensity, a dermal filler for the treatment of moderate to severe dynamic perioral rhytids. It has a collaboration and license agreement with Viatris Inc. to develop, manufacture, and commercialize onabotulinumtoxinA. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Today's Range

Now: $3.40

$3.21

$3.56

50 Day Range

MA: $5.03

$3.29

$7.14

52 Week Range

Now: $3.40

$3.21

$37.98

Volume

2,279,913 shs

Average Volume

1,803,125 shs

Market Capitalization

$354.35 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.05

Who are the company insiders with the largest holdings of Revance Therapeutics?: Revance Therapeutics' top insider investors include:
Mark J Foley (CEO)
Tobin Schilke (CFO)
Dustin S Sjuts (President)
Dwight Moxie (Insider)
Erica Jordan (Insider)
Dwight Moxie (SVP)
Carey Oconnor Kolaja (Director)
Learn More about top insider investors at Revance Therapeutics.
Who are the major institutional investors of Revance Therapeutics?: Revance Therapeutics' top institutional investors include:
Rice Hall James & Associates LLC — 0.72%
Los Angeles Capital Management LLC — 0.09%
Simplex Trading LLC — 0.00%
Learn More about top institutional investors of Revance Therapeutics stock.
Which major investors are selling Revance Therapeutics stock?: During the last quarter, RVNC stock was sold by these institutional investors:
Rice Hall James & Associates LLC
Within the previous year, company insiders that have sold Revance Therapeutics company stock include:
Mark J Foley (CEO)
Tobin Schilke (CFO)
Dustin S Sjuts (President)
Dwight Moxie (Insider)
Erica Jordan (Insider)
Dwight Moxie (SVP)
Carey Oconnor Kolaja (Director)
Learn More investors selling Revance Therapeutics stock.
Which major investors are buying Revance Therapeutics stock?: Within the last quarter, RVNC stock was purchased by institutional investors including:
Los Angeles Capital Management LLC
Simplex Trading LLC